Skip to content

Magnesium blocks the buttocks pain that may appear after spinal anesthesia

Magnesium associated to intratecal lidocaine decreases the incidence of the Transitory Neurologic Syndrome following same-day-surgery - MAGLIDIT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-004538-40-ES
Enrollment
Unknown
Registered
2012-11-12
Start date
2013-01-28
Completion date
Unknown
Last updated
2014-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postanesthetic transitory neurologic syndrome

Interventions

Trade Name: MAGNESIO LAVOISIER Pharmaceutical Form: Solution for injection/infusion Trade Name: Fentanest Pharmaceutical Form: Solution for injection/infusion

Sponsors

Hospital General de Ciudad Real
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Same day surgery 2. Both genders. Pregnancy in fertile women ruled out by serum or urine check preoperatively. 3. Operated in lithotomy position or 4. Arthroscopy position or 5. Obese in any position, with infraumbilical incision 6. Spinal lidocaine anesthetic aine anesthesia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: a) Younger than 18 years old or older than 80 years old. b) American Society of Anesthesia class 3 or 4 c) Active low back pain d) Any myopathy or neuropathy e) Pregnant or breast-feeding women f) Known allergy or sensitivity to lidocaine, magnesium or fentanyl g) Known intracardiac electrical conduction defect seen in the electrocardiogram

Design outcomes

Primary

MeasureTime frame
Main Objective: Determine rate of postanesthetic transitory neurologic syndrome (buttocks pain);Secondary Objective: 1. Time to home discharge 2. Duration of sensitive block 3. Ammount of postoperative analgesia needed 4. Duration of motor block 5. Time to voiding 6. Time to oral intake 7. Posoperative nausea(vomiting rate 8. Inadequate anesthesia rate and conversion to general anesyhesia 9. Rate of unexpected ward admisssion and reason for;Primary end point(s): Postoperative Transitory neurologic syndrome (buttocks pain) rate;Timepoint(s) of evaluation of this end point: Second, fourth and sixth posoperative day

Secondary

MeasureTime frame
Secondary end point(s): 1. Time to home discharge 2. Duration of sensitive block 3. Ammount of postoperative analgesia needed 4. Duration of motor block 5. Time to voiding 6. Time to oral intake 7.Posoperative nausea/vomiting rate 8. Inadequate anesthesia rate and conversion to general anesyhesia 9. Rate of unexpected ward admisssio and reason;Timepoint(s) of evaluation of this end point: Inmediate postoperative hours till dischage from the unit

Countries

Spain

Contacts

Public ContactUnidad de Investigación

Hospital General Universitario de Ciudad Real

eseguram@sescam.jccm.es34926278000313

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026